We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Aims to Rid Pharma of Pay For Performance Sales Practices
U.S. Aims to Rid Pharma of Pay For Performance Sales Practices
The U.S. Department of Justice wants to rid the pharmaceutical industry of pay-for-performance sales compensation packages, believing they fuel fraud, off-label marketing and other deceptive behaviors, a former top prosecutor says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor